ArticleDrug safety2021

Changes in Erythropoiesis Stimulating Agent Use Under a Risk Evaluation and Mitigation Strategy (REMS) Program.

Ameet Sarpatwari et al.PubMed ↗Publisher ↗

No numbers read from the abstract.